SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-14-037626
Filing Date
2014-05-12
Accepted
2014-05-12 16:16:09
Documents
10
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a14-9603_110q.htm 10-Q 800338
2 EX-31.1.1 a14-9603_1ex31d1d1.htm EX-31.1.1 12289
3 EX-31.2.1 a14-9603_1ex31d2d1.htm EX-31.2.1 12361
4 EX-32.1 a14-9603_1ex32d1.htm EX-32.1 6966
  Complete submission text file 0001104659-14-037626.txt   8068129

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT osir-20140331.xml EX-101.INS 1082561
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT osir-20140331.xsd EX-101.SCH 87050
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT osir-20140331_cal.xml EX-101.CAL 74147
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT osir-20140331_def.xml EX-101.DEF 345728
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT osir-20140331_lab.xml EX-101.LAB 1368785
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT osir-20140331_pre.xml EX-101.PRE 633910
Mailing Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046
Business Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046 443-545-1819
OSIRIS THERAPEUTICS, INC. (Filer) CIK: 0001360886 (see all company filings)

IRS No.: 710881115 | State of Incorp.: MD | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32966 | Film No.: 14833605
SIC: 2836 Biological Products, (No Diagnostic Substances)